Followers | 25 |
Posts | 1513 |
Boards Moderated | 0 |
Alias Born | 12/14/2006 |
Tuesday, February 04, 2014 5:15:04 PM
http://ih.advfn.com/p.php?pid=nmona&article=60904541
Disclaimer: Information is offered for discussion purposes only and is not guaranteed to be complete, unbiased, current or accurate and is subject to change without notice and is not be relied upon to make any investment decisions.
Recent DXCM News
- Exxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian Surprises with Revenue Boost and Co-CEO Exit, and More in Earnings • IH Market News • 04/26/2024 11:47:51 AM
- Dexcom Reports First Quarter 2024 Financial Results • Business Wire • 04/25/2024 08:03:00 PM
- U.S. Futures Drop in Pre-Market Trading as Tech Stocks Plunge After Meta Issues Gloomy Forecast • IH Market News • 04/25/2024 11:53:54 AM
- Dexcom Publishes Annual Sustainability Report • Business Wire • 04/03/2024 01:00:00 PM
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time • Business Wire • 04/02/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:04:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:47:23 PM
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter • Business Wire • 03/05/2024 09:26:00 PM
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD • Business Wire • 03/05/2024 06:20:00 PM
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD • Business Wire • 03/05/2024 08:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 09:07:44 PM
- Dexcom Announces Upcoming Conference Presentation • Business Wire • 02/27/2024 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 10:31:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:48:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:09:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:15:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 10:14:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:03:15 PM
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results • Business Wire • 02/08/2024 09:02:00 PM
- U.S. Index Futures Dip Slightly, Oil Prices Climb • IH Market News • 02/08/2024 10:56:39 AM
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People • Business Wire • 02/06/2024 07:00:00 AM
- Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time • Business Wire • 01/23/2024 01:30:00 PM
- Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland • Business Wire • 01/19/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 11:56:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM